Vijaya Diagnost.

VIJAYA03 May 2024

Healthcare

₹

-0.15 (-0.02%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Vijaya Diagnost.

Vijaya Diagnost.

Healthcare

VIJAYA03 May 2024

₹

-0.15 (-0.02%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-May-2023	D	Recommendation of dividend of Re. 1/- per equity share (@100% on a face value of Re. 1/- per share) for the year ended March 31, 2023, subject to approval of the Shareholders at the forthcoming Annual General Meeting ('AGM') of the Company. The dividend shall be credited / warrants thereof dispatched within specified timelines from the conclusion of the AGM. The AGM date and record date for the purpose of the payment of dividend will be announced in due course.	13-Sep-2023
26-May-2022	D	We hereby inform you that the Board of Directors of the Company at their meeting held today has, inter-alia approved the following items of business. Recommended final dividend of 100% i.e. Re 1/- per equity share of face value of Re. 1/- each, for the Financial year ended March 31, 2022 and the said Dividend, if approved and declared by the shareholders at the forthcoming Annual General Meeting (AGM), will be paid within 30 days from the date of the AGM. The date of AGM and record date for the purpose of AGM and Dividend will be intimated in due course.	20-Sep-2022
29-Apr-2024	BC	Final Dividend & Audited Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and app	08-May-2024
12-Feb-2024	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda	13-Feb-2024
23-Jan-2024	BC	Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve 1. The Unaudited standalone and co	05-Feb-2024
19-Dec-2023	BC	We hereby inform you that the Board of Directors of Vijaya Diagnostic Centre Limited ('the Company'), at their meeting held today, (i.e. December 19, 2023), have inter-alia considered and approved th	19-Dec-2023
13-Nov-2023	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Wednes	15-Nov-2023

No Rights has been declared by VIJAYA

Book Closure

Record Date	Split Date	Purpose
08-May-2024	-	Final Dividend & Audited Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and app
13-Feb-2024	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda
05-Feb-2024	-	Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve 1. The Unaudited standalone and co
19-Dec-2023	-	We hereby inform you that the Board of Directors of Vijaya Diagnostic Centre Limited ('the Company'), at their meeting held today, (i.e. December 19, 2023), have inter-alia considered and approved th
15-Nov-2023	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Wednes

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Vijaya Diagnostic Centre Ltd ₹675.35(-0.15/-0.02%)	675.35	-0.15	6,913.45	77.83	61.46	11.59
Kovai Medical Center & Hospital Ltd ₹4,012.25(-48.45/-1.19%)	4,012.25	-48.45	4,442.41	105.40	28.10	5.69
Shree Pacetronix Ltd ₹219.35(-11.50/-4.98%)	219.35	-11.50	83.09	89.22	21.24	7.33
Fortis Malar Hospitals Ltd ₹87.41(-1.78/-2.00%)	87.41	-1.78	167.16	79.96	0.00	2.93
Chennai Meenakshi Multispeciality Hospital Ltd ₹35.99(+0.48/1.35%)	35.99	+0.48	26.53	70.48	98.64	148.77
Apollo Hospitals Enterprise Ltd ₹5,981.40(+25.40/0.43%)	5,981.40	+25.40	85,638.14	32.88	85.76	11.74

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	129.12	136.13	118.73	118.33	110.97	118.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	129.12	136.13	118.73	118.33	110.97	118.26
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	5.25	6.92	5.86	4.53	3.72	3.39
Total Income	134.37	143.04	124.59	122.86	114.69	121.66
Total Expenditure	80.08	79.76	71.24	70.24	67.28	70.30
PBIDT	54.29	63.29	53.35	52.62	47.41	51.36
Interest	6.05	5.84	5.87	5.76	5.53	4.85
PBDT	48.24	57.45	47.48	46.86	41.88	46.51
Depreciation	14.40	13.66	12.44	11.32	20.20	15.80
Tax	9.07	8.62	7.10	7.82	5.84	6.75
Deferred Tax	-0.48	2.32	1.94	0.80	-0.32	1.01
Reported Profit After Tax	25.25	32.85	26.00	26.92	16.16	22.94
Extra-ordinary Items	-1.50	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	26.75	32.85	26.00	26.92	16.16	22.94

EPS (Unit Curr.)	2.47	3.21	2.55	2.64	1.58	2.25
EPS (Adj) (Unit Curr.)	2.47	3.21	2.55	2.64	1.58	2.25
Calculated EPS (Unit Curr.)	2.47	3.21	2.55	2.64	1.58	2.25
Calculated EPS (Adj) (Unit Curr.)	2.47	3.21	2.55	2.64	1.58	2.25
Calculated EPS (Ann.) (Unit Curr.)	9.87	12.85	10.18	10.55	6.33	8.99
Calculated EPS (Adj) (Ann.) (Unit Curr.)	9.87	12.85	10.18	10.55	6.33	8.99
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.23	10.23	10.21	10.21	10.21	10.21
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	42.05	46.49	44.93	44.47	42.72	43.43
PBDTM(%)	37.36	42.20	39.99	39.60	37.74	39.33
PATM(%)	19.56	24.13	21.90	22.75	14.56	19.40

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	132.69	138.86	121.05	120.99	113.12	120.75
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	132.69	138.86	121.05	120.99	113.12	120.75
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	5.11	6.75	5.71	4.52	3.56	3.30
Total Income	137.80	145.61	126.76	125.51	116.68	124.05
Total Expenditure	82.44	81.49	72.93	71.89	68.83	72.01
PBIDT	55.37	64.12	53.83	53.63	47.84	52.05
Interest	6.06	5.85	5.88	5.77	5.54	4.87
PBDT	49.30	58.26	47.94	47.86	42.30	47.17
Depreciation	14.54	13.69	12.47	11.36	20.28	15.90
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	9.23	8.67	7.11	7.96	5.85	6.78
Deferred Tax	-0.46	2.34	1.98	0.82	-0.29	1.02
Reported Profit After Tax	26.00	33.57	26.38	27.73	16.46	23.47
Minority Interest After NP	0.15	0.25	0.18	0.23	0.09	0.14
Net Profit after Minority Interest	25.85	33.32	26.20	27.49	16.36	23.33

Extra-ordinary Items	-1.51	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	27.36	33.32	26.20	27.49	16.36	23.33

EPS (Unit Curr.)	2.53	3.26	2.57	2.69	1.60	2.29
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.23	10.23	10.21	10.21	10.21	10.20

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	41.73	46.18	44.47	44.33	42.29	43.11
PBDTM(%)	37.15	41.96	39.60	39.56	37.39	39.06
PATM(%)	19.59	24.18	21.79	22.92	14.55	19.44

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.21	10.20	4.53	4.53	4.53	4.53
Reserves Total	534.88	459.78	356.02	272.97	209.04	160.04
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	2.41	2.41
Total Shareholders Funds	545.09	469.98	360.55	277.50	215.98	166.98
Secured Loans	0.00	0.00	0.00	27.90	36.27	25.91
Unsecured Loans	247.56	182.83	136.57	128.39	0.00	0.00
Total Debt	247.56	182.83	136.57	156.29	36.27	25.91
Total Liabilities	792.65	652.81	497.12	433.79	252.25	192.89
APPLICATION OF FUNDS :
Gross Block	785.40	574.78	422.25	377.96	204.27	145.34
Less : Accumulated Depreciation	268.29	211.06	161.68	114.04	67.69	43.46
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	517.11	363.72	260.57	263.92	136.58	101.88
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	27.74	34.17	9.42	9.63	2.71	2.69
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	143.87	59.11	32.50	58.28	73.00	77.43
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.93	4.10	2.50	2.69	2.01	2.25
Sundry Debtors	8.85	9.49	6.64	8.47	10.41	8.88
Cash and Bank	111.43	186.06	188.55	113.66	52.23	17.87
Loans and Advances	8.60	10.45	8.79	5.04	7.70	4.75
Total Current Assets	130.80	210.10	206.47	129.86	72.34	33.76
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	44.41	48.34	26.66	31.95	30.06	23.16
Provisions	5.71	2.44	2.05	2.30	2.71	1.19
Total Current Liabilities	50.11	50.79	28.71	34.25	32.76	24.34
Net Current Assets	80.69	159.31	177.76	95.61	39.58	9.41
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	12.21	9.22	6.67	4.36	2.82	1.76
Deferred Tax Liability	4.51	0.95	0.86	3.05	3.64	1.42
Net Deferred Tax	7.70	8.27	5.81	1.31	-0.82	0.34
Total Assets	777.11	624.58	486.06	428.75	251.04	191.75
Contingent Liabilities	0.00	0.00	0.00	0.36	0.93	3.85

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.21	10.20	4.53	4.53	4.53	4.53
Reserves Total	534.52	458.02	354.47	270.01	200.44	154.82
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	2.41	2.41
Total Shareholders Funds	544.73	468.22	359.00	274.54	207.38	161.76
Minority Interest	1.90	1.32	0.23	-0.40	-0.37	-0.64
Secured Loans	0.00	0.63	1.20	29.57	39.15	29.83
Unsecured Loans	247.56	182.83	139.85	131.66	106.69	3.27
Total Debt	247.56	183.46	141.05	161.23	145.84	33.10
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	7.58	7.53	7.97	7.73	7.33	7.34
Total Liabilities	801.77	660.53	508.25	443.10	360.18	201.56
APPLICATION OF FUNDS :
Gross Block	800.29	589.40	436.89	392.41	348.62	152.22
Less: Accumulated Depreciation	276.38	218.95	169.19	120.81	89.38	33.36
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	523.91	370.45	267.70	271.60	259.24	118.86
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	27.74	34.17	9.42	9.63	2.71	2.69
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	139.03	54.28	27.67	54.71	68.88	73.31
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	2.05	4.28	2.64	2.77	2.18	2.42
Sundry Debtors	9.49	9.77	6.70	8.00	9.13	7.94
Cash and Bank	116.42	192.36	194.24	118.19	52.63	18.12
Loans and Advances	8.71	9.25	7.86	2.72	4.68	1.40
Total Current Assets	136.67	215.65	211.45	131.68	68.62	29.87
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	45.28	49.93	30.63	36.67	43.57	31.26
Provisions	6.36	2.99	2.36	2.48	2.68	1.32
Total Current Liabilities	51.64	52.92	32.99	39.15	46.25	32.58
Net Current Assets	85.03	162.73	178.46	92.52	22.37	-2.71
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	12.76	9.81	6.96	4.63	4.82	2.01
Deferred Tax Liability	4.51	0.95	0.86	3.05	3.64	1.51
Net Deferred Tax	8.25	8.86	6.10	1.58	1.18	0.50
Other Assets	17.81	30.05	18.90	13.06	5.81	8.91
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.06	0.06	0.06

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	10.39	6.31	55.49	9.22	15.87
Net Cash from Operating Activities	162.64	155.42	127.84	108.66	76.56
Net Cash Used In Investing Activities	-108.48	-126.63	-128.82	-34.31	-91.04
Net Cash Used In Financing Activities	-41.26	-24.72	-48.19	-28.08	7.83
Net Inc./Dec In Cash And Cash Equivalents	12.90	4.08	-49.17	46.27	-6.65
Cash And Cash Equivalents At End Of The Year	23.29	10.39	6.31	55.49	9.22

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

54.06%

FII Shareholding

20.09%

DII Shareholding

20.80%

Public Shareholding

5.05%

**Promoter pledged shareholding 54.06%

About Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre Ltd is in the Healthcare sector, having a market capitalization of Rs. 6913.45 crores. It has reported a sales of Rs. 129.12 crores and a net profit of Rs. 25.25 crores for the quarter ended December 2018. The company management includes Sura Surendranath Reddy, Sura Surendranath Reddy,Sunil Chandra Kondapally,Geeta Reddy,C S N Murthy,DUVVURU NAGESHWAR REDDY,SEKHAR PRASAD SINGH,Manjula Anagani, (Vijaya Diagnostic Centre Ltd) among others.

Chairman

Sura Surendranath Reddy

Registered office

3-6-16&17 Street No.19,Himayatnagar,Hyderabad,Telangana,500082

FAX :

Background

Incorporation Year2002

Face Value₹1

Market Lot1

How to buy Vijaya Diagnost. shares on nse?

To buy Vijaya Diagnost. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Vijaya Diagnost. share price today?

The Vijaya Diagnost. shares price on nse is Rs.675.35 today.

What is the market cap of Vijaya Diagnost. shares on BSE ?

The company has a market capitalization of Rs.6913.45Cr

What is the PE & PB ratio of Vijaya Diagnost. shares ?

PE is 61.46 and PB is 11.59

What is the 52 Week High and Low of Vijaya Diagnost. shares?

Vijaya Diagnost. stock price high: Rs.719.5 Vijaya Diagnost. stock price low: Rs.360.15